Iridex (IRIX) Total Debt (2020 - 2021)

Iridex (IRIX) posted quarterly Total Debt of $2.5 million for Q2 2021, little changed quarter-over-quarter from $2.5 million in Q1 2021.

Iridex (IRIX) Total Debt (2020 - 2021) Analysis & Trends

Iridex's Total Debt history runs 2 years deep, the most recent figure standing at $2.5 million for Q2 2021.

In Q2 2021, Total Debt changed N/A year-over-year to $2.5 million; the TTM figure through Apr 2021 stood at $2.5 million (changed N/A YoY), while the FY2021 annual figure was $2.5 million, changed N/A from the prior year.
Total Debt for Q2 2021 stood at $2.5 million, roughly flat from $2.5 million in the prior quarter.
The five-year high for Total Debt was $2.5 million in Q3 2020, with the low at $2.5 million in Q3 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Total Debt (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn	32.61 Bn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn	14.94 Bn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn	27.96 Bn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn	12.62 Bn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn	598.70 Mn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn	10.10 Bn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn	8.68 Bn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn	1.89 Bn
10	Iridex	13.27 Mn	8.59 Mn	4.30 Mn	-

Download Data